Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Competent Cells Market: By Type By Application By End-user and By Geography
Competent Cells Market size was valued at US$ 2.6 billion in 2023, growing at a CAGR of 12.2% from 2024-2030. The alterations of E. coli cell walls enable pass DNA more easily. These types of cells are known as competent cells. Heat shock and calcium chloride methods are used to prepare competent cells. Bacterial cells that receive additional chromosomal DNA and plasmids are known as competent cells. Calcium chloride and heat shock are used to permeate the walls of competent cells. This procedure comprises chilling the bacteria with calcium chloride at 0 degrees Celsius for around 90 seconds then heating them at 47 degrees Celsius for another 90 seconds. The calcium chloride treatment neutralizes the membrane's repulsive action of phospholipid heads, while the heat process provides a temperature gradient that allows DNA to enter competent cells. Cells in the early stages of development are more competent than those in the later stages. In the transformation process, competent cells are utilized.
Study Period
2024-2030Base Year
2023CAGR
12.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Increase in advancements in research of molecular cloning, advent of innovative technologies is expected to drive global competent cells market. Moreover, rise in adoption of competent cells, growing commercial demand for molecular cloned products are expected to trigger the revenue share for competent cells market. However, lack of awareness regarding competent cells, high cost associated with the manufacturing procedures, stringent government regulations are restraints of Global market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2.6 billion |
Market CAGR |
12.2% |
By Type |
|
By Application |
|
By End User |
|
Download Free Sample Report
The competent cells market size was valued at US$ 2.6 billion in 2023
The competent cells market key players are: Bio Dynamics Laboratory (Japan) GCC Biotech (India) SMOBIO Technology (Taiwan) Thermo Fisher Scientific, Inc. (U.S.) QIAGEN N.V. (Germany) OriGene Technologies (U.S.) Merck & Co (Germany) Promega Corporation (U.S.) Bioline (UK) Zymo Research (U.S.)
The competent cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Competent Cells Market Introduction |
2.1.Global Competent Cells Market - Taxonomy |
2.2.Global Competent Cells Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.End Users |
2.2.4.Region |
3. Global Competent Cells Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Competent Cells Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Competent Cells Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Electro Competent Cells |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Chemically Competent Cells |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Competent Cells Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Protein Expression |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cloning |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Mutagenesis |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Lenti-Viral Vector Production |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Large Plasmid Transformation |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Competent Cells Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Pharmaceutical Companies |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Biotechnology Companies |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Research Institutes |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Contract Research Organizations |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Competent Cells Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Electro Competent Cells |
9.1.2.Chemically Competent Cells |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Protein Expression |
9.2.2.Cloning |
9.2.3.Mutagenesis |
9.2.4.Lenti-Viral Vector Production |
9.2.5.Large Plasmid Transformation |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Pharmaceutical Companies |
9.3.2.Biotechnology Companies |
9.3.3.Research Institutes |
9.3.4.Contract Research Organizations |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Electro Competent Cells |
10.1.2.Chemically Competent Cells |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Protein Expression |
10.2.2.Cloning |
10.2.3.Mutagenesis |
10.2.4.Lenti-Viral Vector Production |
10.2.5.Large Plasmid Transformation |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Pharmaceutical Companies |
10.3.2.Biotechnology Companies |
10.3.3.Research Institutes |
10.3.4.Contract Research Organizations |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Electro Competent Cells |
11.1.2.Chemically Competent Cells |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Protein Expression |
11.2.2.Cloning |
11.2.3.Mutagenesis |
11.2.4.Lenti-Viral Vector Production |
11.2.5.Large Plasmid Transformation |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Pharmaceutical Companies |
11.3.2.Biotechnology Companies |
11.3.3.Research Institutes |
11.3.4.Contract Research Organizations |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Electro Competent Cells |
12.1.2.Chemically Competent Cells |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Protein Expression |
12.2.2.Cloning |
12.2.3.Mutagenesis |
12.2.4.Lenti-Viral Vector Production |
12.2.5.Large Plasmid Transformation |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Pharmaceutical Companies |
12.3.2.Biotechnology Companies |
12.3.3.Research Institutes |
12.3.4.Contract Research Organizations |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Electro Competent Cells |
13.1.2.Chemically Competent Cells |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Protein Expression |
13.2.2.Cloning |
13.2.3.Mutagenesis |
13.2.4.Lenti-Viral Vector Production |
13.2.5.Large Plasmid Transformation |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Pharmaceutical Companies |
13.3.2.Biotechnology Companies |
13.3.3.Research Institutes |
13.3.4.Contract Research Organizations |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Bio Dynamics Laboratory (Japan) |
14.2.2.GCC Biotech (India) |
14.2.3.SMOBIO Technology (Taiwan) |
14.2.4.Thermo Fisher Scientific, Inc. (U.S.) |
14.2.5.QIAGEN N.V. (Germany) |
14.2.6.OriGene Technologies (U.S.) |
14.2.7.Merck & Co (Germany) |
14.2.8.Promega Corporation (U.S.) |
14.2.9.Bioline (UK) |
14.2.10.Zymo Research (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players